Skip to main content

Pfizer COVID-19 vaccine efficacy drops to 84% after 6 months, preprint study suggests

A new study involving the Pfizer-BioNTech COVID-19 vaccine suggests the jab’s efficacy drops to around 84% about six months after the second dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.